We found that APG-115 significantly inhibited the expression of anti-apoptotic proteins MCL-1, BCL-xL, and BCL-2 in a dose-dependent model in both the EHEB cell line and CLL patient primary cells (Figure 3). The gene discussed is BCL2L1; the disease is B-cell chronic lymphocytic leukemia.